5 Result(s)

Article

Harmonemia: a universal strategy for flow cytometry immunophenoty**—A European LeukemiaNet WP10 study

F Lacombe, E Bernal, D Bloxham, S Couzens, M G D Porta, U Johansson, W Kern… in Leukemia (2016)

Article

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

Definite progress has been made in the exploration of myelodysplastic syndromes (MDS) by flow cytometry (FCM) since the publication of the World Health Organization 2008 classification of myeloid neoplasms. An...

A Porwit, A A van de Loosdrecht, P Bettelheim, L Eidenschink Brodersen… in Leukemia (2014)

Article

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

Flow cytometry (FC) is increasingly recognized as an important tool in the diagnosis and prognosis of myelodysplastic syndromes (MDS). However, validation of current assays and agreement upon the techniques ar...

T M Westers, R Ireland, W Kern, C Alhan, J S Balleisen, P Bettelheim, K Burbury… in Leukemia (2012)

Article

Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor

Purpose: To investigate the possible correlation between expression of HER2 and vascular endothelial growth factor (VEGF), and to determine the predictive value of these factors in patien...

B. Linderholm, J. Bergqvist, H. Hellborg, U. Johansson, M. Linderholm… in Medical Oncology (2009)